Pressure-Test Your Strategy

Home  /  How We Work  /  Alignment Labs

Commercialization Alignment Labs™

Don’t just review the strategy. Pressure-test it.

Four facilitated Labs where Commercial, Market Access, Patient Services and Finance take positions, name owners, and leave with one strategy every function executes. Delivered through NextGen GTN™.

Book a LabHow the pieces fit →

Why it is needed

Everyone optimizes their piece. No one owns the journey.

Commercial, Brand, Market Access, Patient Services, Finance, IT, Analytics and vendors each optimize to their own plan and metrics. The patient journey spans all of them, and no one owns it end to end. The result is duplicated effort, conflicting priorities, and momentum lost in the seams between functions.

Before launch

Functions building the launch in parallel

Commercial, Market Access and Patient Services each design their piece of the launch on different assumptions, until one shared strategy and one journey owner replace them.

New leadership

A new commercial leader inheriting silos

Functions grew up independently and now pull in different directions. The fix starts with mapping the friction and rebuilding a shared operating rhythm.

Vendor sprawl

Partners each optimizing their own metric

Patient hub, copay, specialty pharmacy and analytics vendors each chase a different KPI, when they should share patient-journey goals and a single scorecard.

How a Lab works

Alignment is not a meeting. It is a decision point.

Commercialization changes as evidence develops, payer feedback arrives and channels take shape. Each Lab is a deliberate point to decide, with the right people in the room.

What comes in

  • Strategy
  • Research
  • Evidence
  • Assumptions
  • Data

What the room answers

  • What has changed?
  • What remains uncertain?
  • What has to be true?
  • Who owns the next decision?

What goes out

A prioritized commercialization roadmap.Not another deck.

The four Labs

Each one decides something the next one needs.

Each Lab is a single six-hour facilitated session. The functions that usually meet one at a time sit at the same table, work from the same frameworks, and leave with the same decision record.

LAB 1

Patient Opportunity

Decides: Where the eligible population is created, how it is found, and who owns each transition in that sequence.

  1. Where eligibility is createdThe eligible population traced to where it actually begins, from diagnosis and testing onward.
  2. How patients are foundThe finding sequence made explicit, so no one assumes the population will surface on its own.
  3. An owner at every transitionA named owner for each handoff between being eligible and being found.
Webinars firstA1 and B1Launch triggerPivotal data in hand. The launch plan starts.Redesign triggerA journey diagnostic shows a pull-through gap.
The Four States of Eligibility
LAB 2

Distribution Architecture

Decides: How the product physically reaches the patient, which networks nest inside which, and what each path can and cannot tell you afterwards.

  1. Every path, mappedHow the product physically reaches the patient, with the networks that nest inside each other named.
  2. A position, not a labelThe distribution position expressed as a vector rather than a label.
  3. Data rights, stated honestlyThe data rights level of each path, with the question each level cannot answer written next to it.
Webinars firstA2, B2, B3, S1 and G1Launch triggerPricing corridor agreed, before channel contracts are drafted.Redesign triggerA channel or network contract renewal window.
The Distribution Architecture StackThe Transaction Chain
LAB 3

Leakage Architecture

Decides: Where the journey leaks, who owns each seam, how affordability is designed, and what gets specified into service provider contracts.

  1. A journey designed, not inheritedThe access architecture and the patient journey designed on purpose, with an owner at each seam.
  2. The Gross-to-Net architecture beneath itHow affordability is designed, and what each design choice does to the number.
  3. Contract-ready specificationsA specialty pharmacy scorecard to run against RFP responses, and the field-level data specification.
Webinars firstA3, A4, A5, B4, G2 and G3Launch triggerRegulatory submission, or the specialty pharmacy funding gate.Redesign triggerA patient hub, specialty pharmacy or affordability program RFP or renewal.
The Affordability Grid
LAB 4

Launch Readiness

Decides: What gets measured, what gets inferred, what stays dark, and how field and program resources are deployed against it.

  1. The measurement ledgerEvery observed field carries a named supplying party and the contract clause that obligates it.
  2. The engagement modelHow field and program resources are deployed against what can and cannot be seen.
  3. Site prioritizationSites tiered on observed testing and prescribing behavior, not assumption.
Webinars firstA6, B5, B6, G4 and G5Launch triggerDay −180, six months to the expected approval date. The launch clock is running.Redesign triggerGo-live of the redesigned journey, or a new plan year.
The Three Tiers of Visibility

Every Lab is contracted individually. There is no series minimum and no bundle requirement, and you can stop after any Lab.

The sequence

Learn first, then decide.

All eighteen webinar sessions run in catalog order, and each Lab lands right after the lessons it needs. Spaced about six months apart, the four Labs carry a first launch through Phase 1, Pre-Launch and Launch Readiness, whatever the size of the company. An in-market brand redesigning its patient journey runs the same sequence on its own triggers.

The webinar and Lab sequence across Phase 1Four columns, one per Lab, about six months apart from roughly 24 months before launch. Before Lab 1 come A1 and B1. Before Lab 2 come A2, B2, B3, the 340B session S1 and G1. Before Lab 3 come A3, A4, A5, B4, G2 and G3. Before Lab 4 come A6, B5, B6, G4 and G5. Each side runs in catalog order. Below each Lab sit its launch trigger and its trigger for an in-market brand redesign.SIDE APATIENTSSIDE BPROFITABILITYGOVERNMENTPRICING AND 340BTHE LABMONTHS TO LAUNCHLAUNCH TRIGGERREDESIGN TRIGGERLAUNCH →A1 Patient Journey FoundationsB1 Defensible ForecastingLAB 1Patient OpportunityAbout 24 monthsPivotal data in hand.The launch plan starts.A journey diagnosticshows a pull-through gap.A2 Channels & CommercializationArchitectureB2 Where Possibility MeetsPermissionB3 Building the Road on PurposeS1 The Many Faces of 340BG1 The Government PricingEcosystemLAB 2Distribution ArchitectureAbout 18 monthsPricing corridor agreed,before channel contracts.A channel or networkcontract renewal window.A3 Coverage & AuthorizationA4 The Prescription TransactionA5 Affordability & UtilizationB4 What the Card Doesn’t SayG2 The Transaction MattersG3 The Ripple EffectLAB 3Leakage ArchitectureAbout 12 monthsRegulatory submission,or the specialtypharmacy funding gate.A patient hub, specialtypharmacy or affordabilityRFP or renewal.A6 The Last Mile andWhat FollowsB5 The Two LedgersB6 The Leakage LedgerG4 Government Pricing at LaunchG5 Modeling the MoneyLAB 4Launch ReadinessAbout 6 monthsDay −180. Six monthsto the expectedapproval date.Go-live of theredesigned journey,or a new plan year.

Scroll sideways to follow the sequence.

Timing is typical for a first launch and moves with the program. Vocabulary early, consequence late.

What alignment puts in place

One strategy every function executes.

One cross-functional commercialization strategy.
Clear ownership of the end-to-end patient journey.
Shared goals and metrics across functions.
A coordinated vendor and partner ecosystem.

The fragmentation falls away, and the journey finally has an owner.

Ready to put one strategy behind every function?

Two minutes shows where your functions pull apart. A 30-minute conversation shows which Lab to start with.

Pressure-Test Your StrategyTalk it through →